Pralidoxime_Buy_Q&A.pdf

PDF 527 KB Posted

Attached to
Pralidoxime (Protopam) 1 GM Powder Vial for Injection
Solicitation number
75A50119Q00034
Issued by

About this file

Response to Questions Received

View the file

Other files

File Type Posted
Pralidoxime_Solicitation_CO_signed.pdf PDF
Pralidoxime_Solicitation_CO_signed.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Pralidoxime Buy Q&A

75A50119Q00034

09/09/2019

1. Were you able to find out if your stakeholder can accept clinical trial material or EU approved material? Either option would have a ANDA to be filed (which is on the fast track list with the

FDA).

A: No, we can only accept FDA approved product.

2. Is this an unrestricted solicitation?

A: Yes, this is a full and open competition.

3. Could a partial bid (quotation) be accepted?

A: No, an acceptable quotation must be for all requested product to be delivered within one year of time of contract award.

4. The standard form 1449 block 10. Offer Due Date Local Time; indicates 9/12/2019 1700 ET, and on your cover page states our quotation must be received no later than 5pm eastern time on Thursday, September 10th. Can you clarify which date is the official response date?

A: The official response time is 5 PM ET on 9/12/2019. The cover page has been updated accordingly.

File details come from the government source that posted it.